Finacrest Weekly Market & Economy Wrap
SEBI’s Big Push for Large IPOs
SEBI has amended the Securities Contracts (Regulation) Rules, 1957 to ease listing norms for mega companies:
New Minimum Public Offer (MPO):
Firms > ₹50,000 cr market cap: ₹1,000 cr + 8% stake
₹1–5 lakh cr market cap: ₹6,250 cr + 2.75%
₹5 lakh cr: ₹15,000 cr + 1% (minimum 2.5%)
Extended timeline: 10 years to meet 25% Minimum Public Shareholding (MPS).
Anchor investors: Allocation raised to 40% of IPO size, with defined quotas for insurance, pension, and mutual funds.
Impact: Reduces upfront dilution pressure, lowers execution risk, and makes India attractive for mega listings. FY26 pipeline: ₹2.58 lakh crore IPOs expected.
Pharma Spotlight – Mounjaro Surges Ahead
Eli Lilly’s Mounjaro, a weight-loss drug, became India’s biggest pharma brand by sales in just 6 months:
August sales: ₹120 cr (annual run-rate > ₹1,000 cr).
Surpassed GSK’s Augmentin (₹845 cr in 12 months).
Patent expiry of Semaglutide (2026) may bring a wave of generics → lowering prices but intensifying competition.
Market projection: GLP-1 drugs could reach ₹9,000 cr ($1 bn) by FY30.
Insight: India is gearing up with new facilities, API lines, and global supply readiness — weight management drugs may redefine pharma growth.
Corporate & Regulatory Updates
Gameskraft scandal: Ex-CFO Ramesh Prabhu confessed to diverting company funds into F&O trades, losing >₹250 cr.
GST Relief: Rate cuts for medicines avoid costly recalls; bricks remain at 12%, tobacco stays at 28% until Covid-era borrowings are cleared.
Healthcare IPO Watch
Manipal Hospitals revives one of Asia’s largest IPOs post Sahyadri acquisition.
May leverage SEBI’s relaxed large-issuer norms: ₹6,250 cr + 2.75% dilution if valued >₹1 lakh cr.
IPO buzz rises: Retail interest is strong; GMPs (grey market premiums) hitting 55% above issue price.
Precious Metals – Gold & Silver Rally
Gold: Hit record $3,683/oz (+43% YTD). Indian MCX futures at ₹1.1 lakh per 10 gm.
Drivers: Geopolitical tensions, central bank buying, Fed rate-cut signals.
Risk: Overheated levels may correct if inflation cools or global tensions ease.
Silver: $41.98/oz, up 39% YTD. Dual role as safe haven + industrial metal (solar, EV batteries, semiconductors).
Takeaway: Gold remains a 10–15% portfolio hedge; silver benefits from clean-energy demand but comes with volatility.
Banking & Corporate Deals
Private banks push for more autonomy in CEO & board appointments, lobbying to reduce RBI’s control.
M&A buzz: Warburg Pincus to exit IndiaFirst Life; Cloudnine & Rainbow eye Apollo Cradle; KKR planning ₹600–700 mn infra exits.
Global & Geopolitical
Fed Rate Cut: US Federal Reserve reduced rates by 25 bps. Market expects two more cuts in 2025. Emerging markets, including India, may benefit from softer dollar flows.
Trump Trade & Tariffs: Indian exports diversify (Germany up, US slowing). Equity markets cautious amid valuation concerns.
H-1B Visa Fee Shock: Trump hikes H-1B visa fee to $100,000/year. Major impact on Indian IT workers & firms; India warns of family disruptions.
Tech & Economy
iPhone 17: Strong India pre-orders; expected 15–20% of Apple’s shipments this quarter.
AI in India: BharatGen building a 1T-parameter LLM; Fractal Analytics working on a 70B model for healthcare/STEM.
UPI Insights: Fast-food payments up 255% YoY; department store payments down 80% → consumer shift in spending.
Market Pulse
India’s market cap crossed ₹465 lakh cr, an 11-month high (+₹20 lakh cr in Sept).
Infra.Market raises ₹730 cr (valuation: ₹24,600 cr). IPO filing soon.
Gen Z tourism boom: Festive travel surges — 30% higher flight bookings, 25% bus bookings.
Key Takeaways for Investors
SEBI reforms create a smoother path for mega IPOs – watch out for FY26 listings.
Pharma’s weight-loss wave (Mounjaro vs Semaglutide) could redefine the sector.
Gold & silver remain defensive hedges, but timing is key.
Global Fed policy and Trump tariffs = volatility ahead; emerging markets like India may still shine.
Tech & AI investments in India gaining traction; consumer patterns shifting via UPI data.
Stay Updated
Subscribe to our Finacrest Weekly Insights to get curated updates on markets, policy, wealth, and global economy straight to your inbox.